QID 20258

Date Published: 2022-05-19

QID 20258: IBM DB2 Arbitrary Code Execution Vulnerability (6573293)

DB2 is a family of data management products, including database servers, developed by IBM.

CVE-2022-23852:Expat (aka libexpat) could allow a remote attacker to execute arbitrary code on the system, caused by an integer overflow in the XML_GetBuffer function. By sending a specially-crafted request, an attacker could exploit this vulnerability to execute arbitrary code on the system.
CVE-2022-23990:Expat (aka libexpat) could allow a remote attacker to execute arbitrary code on the system, caused by an integer overflow in the doProlog function. By sending a specially-crafted request, an attacker could exploit this vulnerability to execute arbitrary code on the system.

Affected Versions:
IBM DB2 prior to V9.7 FP11
IBM DB2 prior to V10.1 FP6
IBM DB2 prior to V10.5 FP11
IBM DB2 prior to V11.1.4 FP 7
QID Detection Logic: Authenticated (DB2): This QID queries the DB2 server to get the server version and fix pack level and checks to see if it's vulnerable.

Authenticated (Windows): This QID checks for vulnerable version of DB2 on windows OS

attacker could exploit this vulnerability to execute arbitrary code on the system.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as High - 7.5 severity.
    • Solution

    Please refer to the following links 6573293

    Vendor References

    CVEs related to QID 20258

    CVE-2022-23852 | CVE-2022-23990 |
    Software Advisories
    Advisory ID Software Component Link
    6573293 URL Logo www.ibm.com/support/pages/node/6573293
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].